| Predicted Trait | |
| Reported Trait | Intracerebral hemorrhage |
| Mapped Trait(s) | intracerebral hemorrhage (EFO_0005669) |
| Score Construction | |
| PGS Name | GRS_ICH |
| Development Method | |
| Name | LDpred2-grid |
| Parameters | h2=0.7288, p=0.1, sparse=FALSE |
| Variants | |
| Original Genome Build | NR |
| Number of Variants | 682,890 |
| Effect Weight Type | beta |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000450 |
| Citation (link to publication) | Mayerhofer E et al. Stroke (2023) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 3,026 individuals (100%) |
| Score Development/Training | European: 100% 862 individuals (100%) |
| PGS Evaluation | |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
|---|---|---|---|
GWAS Catalog: GCST002389 Europe PMC: 24656865 | 3,026 individuals | European | NR |
Study Identifiers
|
Sample Numbers
|
Sample Ancestry
|
Cohort(s)
|
Phenotype Definitions & Methods
|
Age of Study Participants
|
Participant Follow-up Time
|
Additional Ancestry Description
|
Additional Sample/Cohort Information
|
|---|---|---|---|---|---|---|---|---|
| — | [ ,
59.0 % Male samples | European | UKB | Cases with history of ICH at baseline and the same number of randomly selected age- and sex-matched ... ICH-free controls.Show more | Mean = 60.0 years | Mean = 11.9 years | — | — |
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source
|
Trait
|
PGS Effect Sizes (per SD change) |
Classification Metrics
|
Other Metrics
|
Covariates Included in the Model
|
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM017258 | PSS010179| Multi-ancestry (including European)| 5,530 individuals | PGP000450 | Mayerhofer E et al. Stroke (2023) | Reported Trait: Incident intracerebral hemorrhage in anticoagulation therapy | HR: 1.24 [1.01, 1.53] | — | R²: 0.02 | age at baseline (controls) or ICH event (cases), sex, PC1 to 10, and genotyping array | — |
| PPM017259 | PSS010179| Multi-ancestry (including European)| 5,530 individuals | PGP000450 | Mayerhofer E et al. Stroke (2023) | Reported Trait: Incident intracerebral hemorrhage in anticoagulation therapy | HR: 1.33 [1.11, 1.59] | C-index: 0.57 [0.5, 0.64] | — | age at baseline (controls) or ICH event (cases), sex, PC1 to 10, and genotyping array, clinical risk... scoreShow more | — |
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods
|
Participant Follow-up Time
|
Sample Numbers
|
Age of Study Participants
|
Sample Ancestry
|
Additional Ancestry Description
|
Cohort(s)
|
Additional Sample/Cohort Information
|
|---|---|---|---|---|---|---|---|---|
| PSS010179 | The test cohort consisted of individuals without a history of ICH at baseline and anticoagulant use ... defined by self-report in the verbal interview at inclusion. Furthermore, individuals were included if they had a diagnosis of the International Classification of Diseases, Tenth Revision code Z92.1 (personal history of long-term (current) use of anticoagulants) or D68.3 (hemorrhagic disorder due to circulating anticoagulants) at baseline or a prescription of an anticoagulant medication between baseline and 6 months thereafter in the primary care dataShow more | Mean = 11.9 years | [ ,
69.0 % Male samples | Mean = 62.0 years | European | — | UKB | — |
| PSS010179 | The test cohort consisted of individuals without a history of ICH at baseline and anticoagulant use ... defined by self-report in the verbal interview at inclusion. Furthermore, individuals were included if they had a diagnosis of the International Classification of Diseases, Tenth Revision code Z92.1 (personal history of long-term (current) use of anticoagulants) or D68.3 (hemorrhagic disorder due to circulating anticoagulants) at baseline or a prescription of an anticoagulant medication between baseline and 6 months thereafter in the primary care dataShow more | Mean = 11.9 years | [ ,
69.0 % Male samples | Mean = 62.0 years | Not reported | — | UKB | — |